<DOC>
	<DOCNO>NCT02500654</DOCNO>
	<brief_summary>The purpose study evaluate surgical treatment peri-implantitis enamel matrix derivative ( Emdogain® , EMD ) additional effect heal outcome , change peri-implant microflora inflammatory response periimplant pocket 12 month .</brief_summary>
	<brief_title>Regenerative Surgical Treatment Peri-implantitis</brief_title>
	<detailed_description>This randomise controlled clinical trial . Recruiting 31 patient periimplantitis one implant need surgical treatment . Randomisation test group ( EMD ) surgical treatment additional application enamel matrix derivative ( Emdogain® ) surgical treatment alone control group ( non-EMD ) . Treatment exist periodontitis perform recruitment . Baseline examination include sample microbiota peri-implant fluid follow surgical treatment . Access surgery remove chronic inflammatory tissue clean implant surface biofilm implant stone hand instrument ultrasonic device special tip implant , follow polish implant surface gauze , super floss rinse saline . Allocation perform block randomisation stage surgery , clean implant surface . Application enamel matrix derivative ( Emdogain® ) , closure flap . After surgery rinse chlorhexidine 0.2 % twice day 6 week . No systemic antibiotic use study . Supportive care program , include hygiene instruction professional cleaning supragingival implant teeth 2 week , 3 , 6 , 9 12 month treatment . Examination measurement pocket depth bone level radiographs baseline surgery 12 month prevalence bleed probing , pu recession well full mouth plaque score full mouth bleed score 3 , 6 , 9 12 month . Microbial sample perform endodontic paper point baseline 2 week surgery well 3 , 6 12 month implant site baseline deepest pocket . Sampling peri-implant fluid peri-implant pocket baseline , 3 , 6 , 12 month implant site baseline deepest pocket . Removal bridge perform give accessibility baseline examination/surgery 12 month .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<mesh_term>Peri-Implantitis</mesh_term>
	<mesh_term>Mouth Diseases</mesh_term>
	<criteria>periimplant angular bone loss ≥3 mm , measure radiograph deep pocket ≥5 mm combine bleed and/or pu individual uncontrolled diabetes ( HbA1c &gt; 7,0 % ) individual prophylaxis antibiotic indicated medication prednisolon antiinflammatory drug medication gingival hyperplasia know side effect systemic antibiotic intake last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Peri-implantitis</keyword>
	<keyword>Regenerative therapy</keyword>
	<keyword>Surgical therapy</keyword>
	<keyword>Enamel matrix derivative</keyword>
	<keyword>Peri-implant microflora</keyword>
	<keyword>Peri-implant fluid</keyword>
</DOC>